Guy's and St Thomas' NHS Foundation Trust
London, SE1 7EH, United Kingdom
NCT Number: NCT03269825
This is a retrospective, observational study and will investigate the clinical predictive value of and change in muscle quantity and quality in critically ill patients with severe respiratory failure requiring veno-venous extracorporeal membrane oxygenation (VV-ECMO).
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
London, SE1 7EH, United Kingdom
The use of veno-venous extra-corporeal membrane oxygenation (VV-ECMO) for severe respiratory failure - mainly hypoxaemia - has increased over recent years. Similar to the general population in the Intensive Care Unit (ICU), these patients become deconditioned, severely weak (ICU acquired weakness- ICUAW) and require prolonged rehabilitation after disconnection from VV-ECMO. However, data regarding the magnitude of muscle wasting and recovery in this specific group is lacking.
Both poor muscle quantity and quality have been found to be a predictor or poor outcome. As all patients receiving VV-ECMO at our hospital will get an initial CT scan of their chest, abdomen and pelvis, these CT scans will be used to measure muscle quantity and quality of different muscle groups of the abdomen at admission and then using any follow-up CT scan performed within 10 days. In addition, the relationship between the loss of muscle over the course of VV-ECMO and perceived recovery of renal function at ICU discharge will be investigated.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: On ECMO (expected to be about 10 days)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: The total duration on ECMO (expected to be an average of 10 days)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: The total duration of ICU admission (expected to be around 2 weeks)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: The total duration of hospital admission (expected to be around 28 days)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: Total duration of mechanical ventilation during intensive care unit stay (expected to be around 10 days)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: After discharge from hospital (expected to be around 28 days)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: The total duration of ECMO (expected to be around 10 days)
Using total muscle quantity measured from CT slice of the third lumbar region.
Time frame: The total duration of ECMO (expected to be around 10 days)
Using total muscle quality measured from CT slice of the third lumbar region.
Time frame: The total duration of ECMO (expected to be around 10 days)
Using total muscle quantity measured from CT slice of the third lumbar region.
Time frame: The total duration of ECMO (expected to be around 10 days)
Using total muscle quantity measured from CT slice of the third lumbar region.
Time frame: Intensive Care Unit Stay (expected to be about 2 weeks)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: 6 months post-ICU discharge
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Time frame: Hospital discharge (expected to be about 28 days)
Using total muscle quantity and quality measured from CT slice of the third lumbar region.
Guy's and St Thomas' NHS Foundation Trust
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06944431
Atrophy, Critical Illness
Taipei, Taiwan
View Trial DetailsNCT05287919
Atrophy, Critical Illness
Temuco, Chile
View Trial DetailsNCT04698798
Atrophy, Body Weight
Hasselt, Belgium
View Trial DetailsNCT04676464
Atrophy, Critical Illness
View Trial Details